Skip to main content
profile image
Selected Works of Philip Mease, MD
Presentation
Secukinumab Provides Sustained Reduction In Fatigue In Patients With Active Psoriatic Arthritis Through 3 Years: Long-term Data From The FUTURE 1 and 2 Studies” 26th Congress European Academy of Dermatology and Venereology (EADV), Geneva, Sept. 2017.
26th Congress European Academy of Dermatology and Venereology (EADV) (2017)
  • RB Warren
  • TK Kvien
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Link
Disciplines
Publication Date
September, 2017
Citation Information
RB Warren, TK Kvien, Philip Mease and et.al.. "Secukinumab Provides Sustained Reduction In Fatigue In Patients With Active Psoriatic Arthritis Through 3 Years: Long-term Data From The FUTURE 1 and 2 Studies” 26th Congress European Academy of Dermatology and Venereology (EADV), Geneva, Sept. 2017." 26th Congress European Academy of Dermatology and Venereology (EADV) (2017)
Available at: http://works.bepress.com/philip-mease/201/